BOTTOMLINE TECHNOLOGIES (DE) (EPAY)

US1013881065 - Common Stock

56.99  +0.49 (+0.87%)

After market: 56.98 -0.01 (-0.02%)

Fundamental Rating

2

Taking everything into account, EPAY scores 2 out of 10 in our fundamental rating. EPAY was compared to 276 industry peers in the Software industry. EPAY may be in some trouble as it scores bad on both profitability and health. EPAY is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year EPAY was profitable.
In multiple years EPAY reported negative net income over the last 5 years.
EPAY had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Industry RankSector Rank
ROA -4.57%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -6.37%
PM (TTM) -7.18%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, EPAY has more shares outstanding
EPAY has a better debt/assets ratio than last year.

2.2 Solvency

EPAY has an Altman-Z score of 4.32. This indicates that EPAY is financially healthy and has little risk of bankruptcy at the moment.
EPAY has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 4.32
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.35 indicates that EPAY should not have too much problems paying its short term obligations.
A Quick Ratio of 1.35 indicates that EPAY should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35

5

3. Growth

3.1 Past

The earnings per share for EPAY have decreased by -0.86% in the last year.
Measured over the past years, EPAY shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.43% on average per year.
The Revenue has grown by 10.10% in the past year. This is quite good.
EPAY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.55% yearly.
EPS 1Y (TTM)-0.86%
EPS 3Y-3%
EPS 5Y-5.43%
EPS growth Q2Q-56.74%
Revenue 1Y (TTM)10.1%
Revenue growth 3Y6.15%
Revenue growth 5Y6.55%
Revenue growth Q2Q9.05%

3.2 Future

The Earnings Per Share is expected to grow by 13.45% on average over the next years. This is quite good.
EPAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.84% yearly.
EPS Next Y-0.66%
EPS Next 2Y10.03%
EPS Next 3Y11.31%
EPS Next 5Y13.45%
Revenue Next Year10.2%
Revenue Next 2Y11.31%
Revenue Next 3Y11.1%
Revenue Next 5Y10.84%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 49.56, the valuation of EPAY can be described as expensive.
The average S&P500 Price/Earnings ratio is at 24.55. EPAY is valued rather expensively when compared to this.
EPAY is valuated quite expensively with a Price/Forward Earnings ratio of 40.93.
The average S&P500 Price/Forward Earnings ratio is at 20.92. EPAY is valued rather expensively when compared to this.
Industry RankSector Rank
PE 49.56
Fwd PE 40.93

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 97.24

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y10.03%
EPS Next 3Y11.31%

0

5. Dividend

5.1 Amount

No dividends for EPAY!.
Industry RankSector Rank
Dividend Yield N/A

BOTTOMLINE TECHNOLOGIES (DE)

NASDAQ:EPAY (5/12/2022, 7:00:02 PM)

After market: 56.98 -0.01 (-0.02%)

56.99

+0.49 (+0.87%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.59B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 49.56
Fwd PE 40.93
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.57%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -6.37%
PM (TTM) -7.18%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-0.86%
EPS 3Y-3%
EPS 5Y
EPS growth Q2Q
EPS Next Y-0.66%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)10.1%
Revenue growth 3Y6.15%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y